Neutrophil extracellular traps enhance platinum resistance in ovarian cancer via SHP-1 activation
Cancer Letters · 2026-04 · 643 · 218288
DOI: 10.1016/j.canlet.2026.218288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-04. Verfasst von Qian Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yan Jiang West Road, Guangzhou, 510120, People's Rep…. Hauptthemen laut MEDLINE: Extracellular Traps, Ovarian Neoplasms, Protein Tyrosine Phosphatase, Non-Receptor Type 6, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Platinum resistance continues to be a major therapeutic challenge in ovarian cancer, driving disease recurrence and limiting patient survival. In this study, we identify a significant enrichment of neutrophil extracellular traps (NETs) within the tumor microenvironment of platinum-resistant ovarian tumors. These NETs actively contribute to malignant progression by promoting epithelial-mesenchymal transition and fostering chemotherapy resistance. Mechanistically, we demonstrate that NETs drive chemoresistance through the unexpected activation of SHP-1. Although traditionally recognized as a tumor suppressor, SHP-1 assumes an oncogenic function in this context. Specifically, NETs trigger TGF-β signaling, resulting in Smad2 phosphorylation, which subsequently promotes both the enzymatic activation and nuclear translocation of SHP-1. Once in the nucleus, SHP-1 enhances RNA polymerase II-mediated transcription and nucleotide excision repair, ultimately enabling cancer cells to evade cisplatin-induced cytotoxicity. Our in vivo experiments corroborate these findings that elevated NETs levels exhibit poor response to cisplatin, while pharmacological inhibition of NETs effectively restores drug sensitivity. This study not only advances our understanding of microenvironment-driven drug resistance but also highlights the therapeutic potential of targeting the NETs/SHP-1 axis to overcome platinum resistance in ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yan Jiang West Road, Guangzhou, 510120, People's Republic of China.
- Guangdong Food and Drug Vocational College, Guangzhou, People's Republic of China.
- Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yan Jiang West Road, Guangzhou, 510120, People's Republic of China; Guangdong Provincial Key Laboratory of Malignant Tumor…
Förderung
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Zhao, Q., Yao, Y., Liang, T., Chen, M., Zeng, M., Li, P., Zhang, S., & Yao, T. (2026). Neutrophil extracellular traps enhance platinum resistance in ovarian cancer via SHP-1 activation. Cancer Letters, 643, 218288. https://doi.org/10.1016/j.canlet.2026.218288
Vancouver
Zhao Q, Yao Y, Liang T, Chen M, Zeng M, Li P, et al. Neutrophil extracellular traps enhance platinum resistance in ovarian cancer via SHP-1 activation. Cancer Letters. 2026;643:218288. doi:10.1016/j.canlet.2026.218288
BibTeX
@article{Zhao2026,
author = {Zhao, Qian and Yao, Yao and Liang, Ting and Chen, Mengjie and Zeng, Minhui and Li, Peixi and Zhang, Shiyi and Yao, Tingting},
title = {Neutrophil extracellular traps enhance platinum resistance in ovarian cancer via SHP-1 activation},
journal = {Cancer Letters},
year = {2026},
volume = {643},
pages = {218288},
doi = {10.1016/j.canlet.2026.218288}
}
EUVIMED